906709 - Nektar Therapeutics - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - NKTR (906709)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

D
2018-04-17
NKTRWhitfield Roy ADirM - OptEx$14.26+30,000192,000+19%+$427,800
D
2018-04-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerM - OptEx$10.69+13,88168,857+25%+$148,388
D
2018-04-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale+OE$101.46-13,88168,857-17%-$1,408,366
D
2018-04-10
NKTRHora ManinderSVP Pharma Dev, Mfg OpsM - OptEx$7.21+50280,261+1%+$3,619
D
2018-04-10
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$105.67-50280,261-1%-$53,046
D
2018-04-05
NKTRLingnau LutzDirM - OptEx$9.24+30,00027,450-1176%+$277,200
D
2018-04-05
NKTRLingnau LutzDirS - Sale+OE$101.74-30,00027,450-52%-$3,052,200
DM
2018-04-05
NKTRHora ManinderSVP Pharma Dev, Mfg OpsM - OptEx$7.21+29,49880,261+58%+$212,681
DM
2018-04-05
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$102.81-29,49880,261-27%-$3,032,765
D
2018-04-06
NKTRGreer R ScottDirM - OptEx$14.26+30,000130,333+30%+$427,800
D
2018-04-06
NKTRGreer R ScottDirS - Sale+OE$92.22-30,000130,333-19%-$2,766,600
DM
2018-04-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerM - OptEx$8.52+160,00067,394-173%+$1,362,400
DM
2018-04-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$93.06-160,00067,394-70%-$14,890,180
D
2018-04-06
NKTRChess RobertDirM - OptEx$8.79+25,000274,223+10%+$219,700
D
2018-04-06
NKTRChess RobertDirS - Sale+OE$92.14-25,000274,223-8%-$2,303,600
DM
2018-03-06
NKTRKuebler Christopher ADirM - OptEx$6.17+40,00040,500>999%+$246,600
DM
2018-03-06
NKTRKuebler Christopher ADirS - Sale+OE$97.60-40,00040,500-50%-$3,903,914
M
2018-03-06
NKTRNicholson JohnSVP, COOS - Sale$99.27-220,144167,513-57%-$21,854,265
2018-02-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$82.94-2,54568,857-4%-$211,082
2018-02-16
NKTRRobin Howard WPres, CEOS - Sale$82.94-12,788237,557-5%-$1,060,637
2018-02-16
NKTRNicholson JohnSVP, COOS - Sale$82.94-4,879387,657-1%-$404,664
2018-02-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$82.94-3,47799,739-3%-$288,382
2018-02-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$82.94-2,87580,261-3%-$238,453
2018-02-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$82.94-2,42667,394-3%-$201,212
D
2018-01-31
NKTRNicholson JohnSVP, COOM - OptEx$11.34+120,000392,536+44%+$1,360,800
D
2018-01-22
NKTRRobin Howard WPres, CEOM - OptEx$11.34+83,333250,345+50%+$944,996
D
2018-01-22
NKTRRobin Howard WPres, CEOS - Sale+OE$75.82-83,333250,345-25%-$6,318,308
D
2018-01-04
NKTRWinger Dennis LDirM - OptEx$11.97+33,75082,000+70%+$403,988
D
2018-01-02
NKTRKuebler Christopher ADirM - OptEx$14.26+30,00040,500+286%+$427,800
D
2018-01-02
NKTRKuebler Christopher ADirS - Sale+OE$58.66-30,00040,500-43%-$1,759,800
D
2017-12-15
NKTRRobin Howard WPres, CEOA - Grant$0.00+60,500250,345+32%+$0
D
2017-12-15
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerA - Grant$0.00+10,40071,402+17%+$0
D
2017-12-15
NKTRNicholson JohnSVP, COOA - Grant$0.00+26,000272,536+11%+$0
D
2017-12-15
NKTRLabrucherie Gil MSVP, CFOA - Grant$0.00+26,000103,216+34%+$0
D
2017-12-15
NKTRHora ManinderSVP Pharma Dev, Mfg OpsA - Grant$0.00+15,00083,136+22%+$0
D
2017-12-15
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerA - Grant$0.00+26,00069,820+59%+$0
D
2017-12-13
NKTRRobin Howard WPres, CEOM - OptEx$11.34+83,333189,845+78%+$944,996
D
2017-12-13
NKTRRobin Howard WPres, CEOS - Sale+OE$55.69-83,333189,845-31%-$4,640,815
D
2017-11-15
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerA - Grant$0.00+15,00060,549+33%+$0
D
2017-11-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerD - Sale to issuer$44.23-5,28960,549-8%-$233,932
D
2017-11-15
NKTRRobin Howard WPres, CEOA - Grant$0.00+55,000189,845+41%+$0
D
2017-11-16
NKTRRobin Howard WPres, CEOD - Sale to issuer$44.23-18,069189,845-9%-$799,192
D
2017-11-15
NKTRNicholson JohnSVP, COOA - Grant$0.00+20,000246,536+9%+$0
D
2017-11-16
NKTRNicholson JohnSVP, COOD - Sale to issuer$44.23-6,620246,536-3%-$292,803
D
2017-11-15
NKTRLabrucherie Gil MSVP, CFOA - Grant$0.00+20,00076,716+35%+$0
D
2017-11-16
NKTRLabrucherie Gil MSVP, CFOD - Sale to issuer$44.23-6,69876,716-8%-$296,253
D
2017-11-15
NKTRHora ManinderSVP Pharma Dev, Mfg OpsA - Grant$0.00+15,00067,636+28%+$0
D
2017-11-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsD - Sale to issuer$44.23-5,59767,636-8%-$247,555
D
2017-11-15
NKTRGergel Ivan P.SVP, Chief Medical OfficerA - Grant$0.00+20,00056,553+55%+$0
D
2017-11-16
NKTRGergel Ivan P.SVP, Chief Medical OfficerD - Sale to issuer$44.23-5,02256,553-8%-$222,123
D
2017-11-15
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerA - Grant$0.00+17,50043,820+66%+$0
D
2017-11-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerD - Sale to issuer$44.23-4,78243,820-10%-$211,508
D
2017-11-13
NKTRNicholson JohnSVP, COOM - OptEx$9.24+25,000233,156+12%+$231,000
D
2017-11-13
NKTRNicholson JohnSVP, COOS - Sale+OE$37.78-15,910233,156-6%-$601,080
DM
2017-11-06
NKTRHora ManinderSVP Pharma Dev, Mfg OpsM - OptEx$17.15+39,71758,233+215%+$680,961
D
2017-11-06
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$25.07-5,11758,233-8%-$128,283
DM
2017-11-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerM - OptEx$9.53+396,32331,102-109%+$3,776,958
DM
2017-11-06
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$29.00-396,32331,102-93%-$11,493,476
D
2017-11-01
NKTRRobin Howard WPres, CEOM - OptEx$11.34+83,334152,914+120%+$945,008
D
2017-11-01
NKTRRobin Howard WPres, CEOS - Sale+OE$23.57-83,334152,914-35%-$1,964,182
D
2017-10-09
NKTRRobin Howard WPres, CEOM - OptEx$11.34+83,333152,914+120%+$944,996
D
2017-10-09
NKTRRobin Howard WPres, CEOS - Sale+OE$24.20-83,333152,914-35%-$2,016,659
D
2017-10-05
NKTRHora ManinderSVP Pharma Dev, Mfg OpsM - OptEx$10.69+7,58358,233+15%+$81,062
D
2017-10-05
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale+OE$25.00-7,58358,233-12%-$189,575
D
2017-10-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerM - OptEx$9.53+43,67731,102-347%+$416,242
D
2017-10-05
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale+OE$24.97-43,67731,102-58%-$1,090,615
D
2017-10-02
NKTRLabrucherie Gil MSVP, CFOM - OptEx$11.34+120,00063,414-212%+$1,360,800
D
2017-10-02
NKTRLabrucherie Gil MSVP, CFOS - Sale+OE$24.45-120,00063,414-65%-$2,934,000
DM
2017-09-29
NKTRGergel Ivan P.SVP, Chief Medical OfficerM - OptEx$11.04+100,00041,575-171%+$1,104,000
DM
2017-09-29
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$24.14-100,00041,575-71%-$2,413,640
2017-09-22
NKTRLingnau LutzDirS - Sale$21.97-5,00027,450-15%-$109,850
2017-09-22
NKTRKuebler Christopher ADirS - Sale$21.86-4,00040,500-9%-$87,440
2017-09-21
NKTRChess RobertDirS - Sale$21.72-6,400274,223-2%-$139,008
D
2017-09-19
NKTRAjer Jeffrey RobertDirA - Grant$0.00+22,50022,500New+$0
D
2017-09-19
NKTRWinger Dennis LDirA - Grant$0.00+9,00048,250+23%+$0
D
2017-09-19
NKTRKuebler Christopher ADirA - Grant$0.00+9,00044,500+25%+$0
D
2017-09-19
NKTRWhitfield Roy ADirA - Grant$0.00+9,000162,000+6%+$0
D
2017-09-19
NKTRLingnau LutzDirA - Grant$0.00+9,00032,450+38%+$0
D
2017-09-19
NKTRKrivulka Joseph JDirA - Grant$0.00+9,00082,000+12%+$0
D
2017-09-19
NKTRGreer R ScottDirA - Grant$0.00+9,000130,333+7%+$0
D
2017-09-19
NKTRChess RobertDirA - Grant$0.00+9,000280,623+3%+$0
D
2017-09-06
NKTRRobin Howard WPres, CEOM - OptEx$11.34+83,333152,914+120%+$944,996
D
2017-09-06
NKTRRobin Howard WPres, CEOS - Sale+OE$21.54-83,333152,914-35%-$1,794,993
2017-08-16
NKTRThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$19.32-2,64850,838-5%-$51,159
D
2017-08-16
NKTRRobin Howard WPres, CEOM - OptEx$11.34+83,334152,914+120%+$945,008
D
2017-08-16
NKTRRobin Howard WPres, CEOS - Sale+OE$19.26-91,714152,914-37%-$1,766,081
2017-08-16
NKTRNicholson JohnSVP, COOS - Sale$19.32-3,177224,066-1%-$61,380
2017-08-16
NKTRLabrucherie Gil MSVP, CFOS - Sale$19.32-3,17763,414-5%-$61,380
2017-08-16
NKTRHora ManinderSVP Pharma Dev, Mfg OpsS - Sale$19.32-2,95658,233-5%-$57,110
2017-08-16
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale$19.32-1,99741,575-5%-$38,582
2017-08-16
NKTRDoberstein Stephen KSVP, Chief Scientific OfficerS - Sale$19.32-1,70131,102-5%-$32,863
2017-08-10
NKTRWhitfield Roy ADirP - Purchase$17.95+35,000153,000+30%+$628,250
D
2017-07-18
NKTRGergel Ivan P.SVP, Chief Medical OfficerM - OptEx$11.04+54,92043,572-484%+$606,317
D
2017-07-18
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$21.10-54,92043,572-56%-$1,158,812
D
2017-07-14
NKTRLingnau LutzDirM - OptEx$14.26+30,00023,450-458%+$427,800
D
2017-07-14
NKTRLingnau LutzDirS - Sale+OE$20.76-30,00023,450-56%-$622,800
DM
2017-07-11
NKTRGergel Ivan P.SVP, Chief Medical OfficerM - OptEx$11.04+45,08043,572-2989%+$497,683
DM
2017-07-11
NKTRGergel Ivan P.SVP, Chief Medical OfficerS - Sale+OE$21.08-45,08043,572-51%-$950,318
D
2017-06-26
NKTRKrivulka Joseph JDirM - OptEx$8.37+15,00073,000+26%+$125,550
D
2017-06-07
NKTRNicholson JohnSVP, COOM - OptEx$6.34+150,000227,243+194%+$951,000

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top